Abbvie M13-594 A Randomized, Open-Label, Active-Controlled, Multicenter Study to Compare Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Co-Administered with Ribavirin in Adults with Chronic Hepatitis C Virus Genotype 3 Infection - Projekt - Autoren - KSSG Forschungsdatenbank

Projekt

Abbvie M13-594 A Randomized, Open-Label, Active-Controlled, Multicenter Study to Compare Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Co-Administered with Ribavirin in Adults with Chronic Hepatitis C Virus Genotype 3 Infection

Abgeschlossen · 2016 bis 2017

Alfter Christine, Semela David

Semela, David

Leitender Arzt Hepatologie
Forschungsgruppenleiter Liver Biology Lab, Departement Biomedizin, Universitätsspital Basel
Leitende(r) Arzt/Ärztin
Gastroenterologie | Hepatologie · Dept. I

Alfter, Christine